Senior medical affairs officials sat down at a roundtable discussion facilitated by the Boston Consulting Group to discuss the role of medical affairs along the pharma value chain. Take a look at the outcome of this discussion and explore the role and challenges of medical affairs in pharma.
Author: Ethan Dabbs
Published: 29 August 2018
Number of pages:7
The role of medical affairs in the pharma industry and its associated challenges are the focus of this insightful article from In Vivo. Based upon the outcome of a roundtable discussion among 14 senior medical affairs officials, and supported by additional data gathered by the Boston Consulting Group, including surveys, interviews, and more, this illuminating article explores the essential, but often forgotten, role of medical affairs. Examine the key trends that may likely increase the influence and importance of medical affairs in the coming years.
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.